Marcadores virológicos en la infección por VHB

Seeger, 2000, Hepatitis B virus biology, Microbiol and Mol Biol Rev, 64, 51, 10.1128/MMBR.64.1.51-68.2000 Okamoto, 1987, Genomic heterogeneity of hepatititis B virus in a 54 year-old woman who contracted the infecion through materno-fetal transmission, Jpn J Exp Med, 57, 231 Arauz-Ruiz, 2002, Genotype H: a new Amerindian genotyoe of hepatitis B virus revealed in Central America, J. Gen Virol, 83, 2059, 10.1099/0022-1317-83-8-2059 Bartholomeusz, 2004, Hepatitis B virus genotypes: comparison of genotyping methods, Rev Med Virol, 14, 3, 10.1002/rmv.400 Fung, 2006, Virologic response and resistance to adefovir in patients with chronic hepatitis B, J Hepatol, 44, 283, 10.1016/j.jhep.2005.10.018 Sánchez-Tapias, 2002, Influence of hepatitis B virus genotype on the long-ter outcome of chronic B in western patients, Gastroenterology, 123, 1848, 10.1053/gast.2002.37041 Wai, 2004, Clinical significance of hepatitis B virus genotypes, variants and mutants, Clin Liver Dis, 8, 321, 10.1016/j.cld.2004.02.006 Perrillo, 2005, Current treatment of chronic hepatitis B: benefits and limitations, Seminars Liv Dis, 25, 20, 10.1055/s-2005-915647 Janssen, 2005, Pegylated interferon alfa 2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial, Lancet, 365, 123, 10.1016/S0140-6736(05)17701-0 McMahon, 2004, The natural history of chronic hepatitis B virus infection, Semin Liv Dis, 24, 17, 10.1055/s-2004-828674 Werle-Lapostolle, 2004, Persistence of cccDNA during the natural history of chronic hepatiti B and decline during adefovir dipivoxil therapy, Gastroenterology, 126, 1750, 10.1053/j.gastro.2004.03.018 Le Mire, 2005, Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persist following transient infection, J Virol, 79, 12242, 10.1128/JVI.79.19.12242-12252.2005 Weber, 2001, Hepatitis B virus (HBV markers in isolated anti-HBc positive individuals), J Med Virol, 64, 312, 10.1002/jmv.1052 Flink, 2006, Treatment with Peg interferon α-2b for HBeAg positive chornic hepatitis B: HBsAg loss is associated with HBV genotype, Am J Gastroenterol, 101, 297, 10.1111/j.1572-0241.2006.00418.x Allain, 2004, Occult hepatitis B infection: implication in transfusion, Vox Sanguinis, 86, 83, 10.1111/j.0042-9007.2004.00406.x Hsu, 2004, Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan, Gut, 53, 1499, 10.1136/gut.2003.034223 Hatzakis, 2006, HBV virological assessment, J Hepatol, 44, S71, 10.1016/j.jhep.2005.11.017 Funk, 2002, World-wide epidemiology of HBeAg negative chronic hepatitis B and associated precore and core promoter variants, J Viral Hepat, 9, 52, 10.1046/j.1365-2893.2002.00304.x Rodríguez-Frías, 1995, Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations, Hepatology, 22, 1641, 10.1002/hep.1840220605 Jardí, 2004, Mutations in the basic core promoter region of hepatitis B virus relationship with precore variants and HBV genotypes in Spanish population of HBV carriers, J Hepatol, 40, 507, 10.1016/j.jhep.2003.11.015 Marrone, 2003, Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A corre promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection, Intervirology, 46, 222, 10.1159/000072431 Tacke, 2004, Basal core promoter and precore mutations in the hepatitis B virus genome enhance replicacion of lamivudine-resistant mutants, J Virol, 78, 8524, 10.1128/JVI.78.16.8524-8535.2004 Chen, 2006, Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B pa-tients with and without HBeAg clearance in lamivudine therapy, J Hepatol, 44, 76, 10.1016/j.jhep.2005.08.022 Neuman, 2005, Hepatitis B viral kinetics: a dynamic puzzle still to be resolved, Hepatology, 42, 249, 10.1002/hep.20831 Weber, 2005, Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic varability of the S gene, Expert Rev Mol Diagn, 5, 75, 10.1586/14737159.5.1.75 Mommeja-Marin, 2003, Serum HBV DNA as a markser of efficacy during therapy for chronic HBV infection: analysis and review of the literature, Hepatology, 37, 1309, 10.1053/jhep.2003.50208 Pawlotsky, 2003, Hepatitis B virus (HBV) DNA assays (methods a practical use) and viral kinetics, J Hepatol, 39, S31, 10.1016/S0168-8278(03)00136-3 Lok, 2004, Chronic Hepatitis B: Update of recomendations, Hepatology, 857, 10.1002/hep.20110 Jardí, 2001, Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay, J Vir Hepat, 8, 465, 10.1046/j.1365-2893.2001.00322.x Manesis, 2003, Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection, Am J Gastroenterol, 98, 2261, 10.1111/j.1572-0241.2003.07715.x Chu, 2002, Quantitative serum HBV DNA levels during differents stages of chronic hepatitis N infection, Hepatology, 36, 1408, 10.1053/jhep.2002.36949 Dusheiko, 2006, Candidates for therapy: HBV, J Hepatol, 44, S84, 10.1016/j.jhep.2005.11.033 De Franchis, 2003, EASL International Consensus Conference on Hepatitis B, J Hepatol, 39, S3, 10.1016/S0168-8278(03)00378-7 Hadziyannis, 2001, Hepatitis B e antigen-negative chronic hepatitis B, Hepatology, 34, 617, 10.1053/jhep.2001.27834 Zoulim, 2006, Assessment of treatment efficacy in HBV infection and disease, J Hepatol, 44, S95, 10.1016/j.jhep.2005.11.020 Sung, 2005, Intrahepatic B virus covalently closed circular DNA can be a predictor of sustained response to therapy, Gastroenterology, 128, 1890, 10.1053/j.gastro.2005.03.009 Durantel, 2005, Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genoypic to phenotypic testing, J Clin Virol, 34, S34, 10.1016/S1386-6532(05)80008-3 Lok, 2002, Monitoring drug resistance in chronic hepatitis B virus (HBV) infected patients during lamivudine therapy: evaluation of performance of INNO-LIPA HBV DR assay, J Clin Microbiol, 40, 3729, 10.1128/JCM.40.10.3729-3734.2002 Rodríguez-Frías F, Jardí R, Buti M, Schaper M, Hermosilla E, Valdés A, et al. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. J Viral Hepatits. 2006; manuscrito JVH 691 en prensa, disponible on-line (24/01/2006). Fung, 2004, Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?, Hepatology, 40, 790, 10.1002/hep.20455 Chu, 2002, Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C, Gastroenterology, 122, 1756, 10.1053/gast.2002.33588 Westland, 2003, Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil, Gastroenterology, 125, 107, 10.1016/S0016-5085(03)00700-5 Zollner, 2004, Viral features of lamivudine rresistant hepatitis B genotypes A and D, Hepatology, 39, 42, 10.1002/hep.20016 Chien, 2003, Determinants for sustained HBeAg response to lamivudine therapy, Hepatology, 38, 1267, 10.1053/jhep.2003.50458 Conjeevaram, 2003, Management of chronic hepatitis B, J Hepatol, 38, S90, 10.1016/S0168-8278(02)00431-2 Moraleda, 1997, Lack of effect of antiviral therapy in non-dividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus, J Hepatol, 71, 9392